"Antimanic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to treat bipolar disorders or mania associated with other affective disorders.
| Descriptor ID |
D018692
|
| MeSH Number(s) |
D27.505.696.277.950.025 D27.505.954.427.210.950.025 D27.505.954.427.700.872.025
|
| Concept/Terms |
Antimanic Agents- Antimanic Agents
- Agents, Antimanic
- Antimanic Drugs
- Drugs, Antimanic
- Antimanics
Antimanic Effect- Antimanic Effect
- Effect, Antimanic
- Antimanic Effects
- Effects, Antimanic
|
Below are MeSH descriptors whose meaning is more general than "Antimanic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antimanic Agents".
This graph shows the total number of publications written about "Antimanic Agents" by people in this website by year, and whether "Antimanic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 5 | 0 | 5 |
| 2017 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antimanic Agents" by people in Profiles.
-
Deligiannidis KM. Question: How Should I Manage Medications for A Patient With A History of Bipolar Disorder Who Would Like to Become Pregnant? J Clin Psychopharmacol. 2024 Jul-Aug 01; 44(4):448-449.
-
Cintr?n Pastrana MA, Irizarry Flores JC, Rothschild AJ. Challenges in the Treatment of Psychotic Bipolar Depression. J Clin Psychopharmacol. 2024 Jul-Aug 01; 44(4):407-412.
-
Katz IR, Rogers MP, Lew R, Thwin SS, Doros G, Ahearn E, Ostacher MJ, DeLisi LE, Smith EG, Ringer RJ, Ferguson R, Hoffman B, Kaufman JS, Paik JM, Conrad CH, Holmberg EF, Boney TY, Huang GD, Liang MH. Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2022 01 01; 79(1):24-32.
-
Smith EG, Austin KL, Kim HM, Miller DR, Sauer BC, Valenstein M. Suicide death over the first year of lithium versus valproate treatment in cohorts with and without bipolar disorder. J Psychiatr Res. 2022 03; 147:349-356.
-
Landersdorfer CB, Findling RL, Frazier JA, Kafantaris V, Kirkpatrick CM. Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics. Clin Pharmacokinet. 2017 01; 56(1):77-90.
-
Miller CJ, Li M, Penfold RB, Lee AF, Smith EG, Nordberg SS, Osser DN, Bajor L, Zhang F, Bauer MS. The Ascendancy of Second-Generation Antipsychotics as Frontline Antimanic Agents. J Clin Psychopharmacol. 2015 Dec; 35(6):645-53.
-
Smith EG. Long-term effects of lithium on renal function. Lancet. 2015 Nov 14; 386(10007):1943.
-
Findling RL, Robb A, McNamara NK, Pavuluri MN, Kafantaris V, Scheffer R, Frazier JA, Rynn M, DelBello M, Kowatch RA, Rowles BM, Lingler J, Martz K, Anand R, Clemons TE, Taylor-Zapata P. Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study. Pediatrics. 2015 Nov; 136(5):885-94.
-
Smith EG, Austin KL, Kim HM, Eisen SV, Kilbourne AM, Miller DR, Zivin K, Hannemann C, Sauer BC, Valenstein M. Mortality associated with lithium and valproate treatment of US Veterans Health Administration patients with mental disorders. Br J Psychiatry. 2015 Jul; 207(1):55-63.
-
Nascimento NF, Carlson KN, Amaral DN, Logan RW, Seggio JA. Alcohol and lithium have opposing effects on the period and phase of the behavioral free-running activity rhythm. Alcohol. 2015 Jun; 49(4):367-76.